These are a collection of reports released by the National Academies on stem cells and stem cell research. Click on the report title to go to the National Academies Press website, where you can buy a copy of the report or download the PDF for free.
In 2005, the National Academies released the book, Guidelines for Human Embryonic Stem Cell Research, which offered a common set of ethical standards for a field that, due to the absence of comprehensive federal funding, was lacking national standards for research. In order to keep the Guidelines up to date, given the rapid pace of scientific and policy developments in the field of stem cell research, the Human Embryonic Stem Cell Research Advisory Committee was established in 2006 with support from The Ellison Medical Foundation, The Greenwall Foundation, and the Howard Hughes Medical Institute. As it did in 2007 and 2008, the Committee identified issues that warranted revision, and this book addresses those issues in a third and final set of amendments. Specifically, this book sets out an updated version of the National Academies’ Guidelines, one that takes into account the new, expanded role of the NIH in overseeing hES cell research. It also identifies those avenues of continuing National Academies’ involvement deemed most valuable by the research community and other significant stakeholders.
This report offers amended guidelines for research involving human embryonic stem cells. It is the second set of amendments to be issued to clarify and update the National Academies’ Guidelines for Human Embryonic Stem Cell Research, which have served as the basis for oversight of this research in the United States since 2005. Its authoring committee was convened by the National Research Council to monitor scientific advances and evaluate the need for revisions to the Guidelines on an ongoing basis, with support from The Ellison Medical Foundation, The Greenwall Foundation, and the Howard Hughes Medical Institute. The amendments offered in this report include guidance in response to recent scientific advances enabling the derivation of human stem cells from nonembryonic tissues, including cells known as “induced pluripotent stem cells,” and clarification on the types of expenses that can be reimbursed to women donating eggs for stem cell research.
In 2005, the National Academies released the report Guidelines for Human Embryonic Stem Cell Research, which offered a common set of ethical standards for a field that, due to the absence of comprehensive federal funding, was lacking national standards for research. In order to keep the Guidelines up to date, given the rapid pace of scientific developments in the field of stem cell research, the Human Embryonic Stem Cell Research Advisory Committee was established in 2006 with support from The Ellison Medical Foundation, The Greenwall Foundation, and the Howard Hughes Medical Institute. This letter report is the committee’s first set of amendments to the Guidelines and clarifies earlier recommendations and conclusions, including the criteria for determining which stem cell lines it is acceptable to use. Future deliberations of the committee will address items for which additional information gathering and more extensive debate and discussion will be necessary.
Since 1998, the volume of research being conducted using human embryonic stem (hES) cells has expanded primarily using private funds because of restrictions on the use of federal funds for such research. Given limited federal involvement, privately funded hES cell research has thus far been carried out under a patchwork of existing regulations, many of which were not designed with this research specifically in mind. In addition, hES cell research touches on many ethical, legal, scientific, and policy issues that are of concern to the public. This report provides guidelines for the conduct of hES cell research to address both ethical and scientific concerns. The guidelines are intended to enhance the integrity of privately funded hES cell research by encouraging responsible practices in the conduct of that research.
Recent scientific breakthroughs, celebrity patient advocates, and conflicting religious beliefs have come together to bring the state of stem cell research specifically embryonic stem cell research into the political crosshairs. President Bush s watershed policy statement allows federal funding for embryonic stem cell research but only on a limited number of stem cell lines. Millions of Americans could be affected by the continuing political debate among policymakers and the public. Stem Cells and the Future of Regenerative Medicine provides a deeper exploration of…[more]
Stem cell research has the potential to revolutionize the treatment of many health problems including chronic heart disease, Type I diabetes, Parkinson’s disease, and spinal chord injuries. This research, however, would require a steady supply of stem cells, particularly human embryonic stem cells, which are created from eggs—or oocytes—harvested from the ovaries of female donors. The egg donation process is not without its risks to the donors. At the request of the California Institute for Regenerative Medicine, the National Academies held a workshop in September 2006 to discuss what is known about these risks, what needs to be known, and what can be done to minimize them. This workshop summary includes discussions of the comparative risks of donating eggs for research versus donating eggs for reproductive purposes, and the likelihood of experiencing medical problems, psychological harm, or complications resulting from the surgical extraction of eggs.
Human reproductive cloning is an assisted reproductive technology that would be carried out with the goal of creating a newborn genetically identical to another human being. It is currently the subject of much debate around the world, involving a variety of ethical, religious, societal, scientific, and medical issues. Scientific and Medical Aspects of Human Reproductive Cloningconsiders the scientific and medical sides of this issue, plus ethical issues that pertain to human-subjects research. Based on experience with reproductive cloning in animals, the report concludes that human reproductive cloning would be dangerous for the woman, fetus, and newborn, and is likely to fail. The study panel did not address the issue of whether human reproductive cloning, even if it were found to be medically safe, would be or would not be acceptable to individuals or society.